Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.

Abstract

OBJECTIVE:

Fork head domain-containing transcription factor family (FOX), is comprised of >20 members. Members of FOX family have been implicated in a wide range of physiological and/or diseased conditions. Many of FOX members have been shown to be involved in tumorigenesis and progression. The potential roles in carcinogenesis of FOXN4, a member as one of the vast FOX family, remains relatively unknown.

METHOD:

Here, we explored the potential involvement of FOXN4 in breast cancer.

RESULTS:

First, observed that a higher FOXN4 was identified in the normal adjacent breast tissue as compared to that in the breast cancer samples; an increased FOXN4 level was associated with a better prognosis in patients with breast cancer. In addition, ectopically expression of FOXN4 led to the decreased cell proliferation, reduced colony formation and metastatic abilities (EMT, migration and invasion) in breast cancer cell lines. Furthermore, we showed the direct interaction between FOXN4 and TP53 and FOXN4 binding led to the increased activity of TP53. Silencing FOXN4 led to reduced TP53 and increased expression of Dll4, Notch and survivin, providing a link between FOXN4 and Notch signaling. Finally, we used patient-derived xenograft mouse model to demonstrate the tumor inhibitory effects of Notch-inhibitor, PF-3084014. We found that PF-3084014 treatment led to a significantly smaller tumor burden and higher survival ratio in patient-derived xenograft mice as compared to the vehicle. This tumor suppressive effect was accompanied by the increased expression of TP53, FOXN4 and decreased Dll4 and Notch.

CONCLUSION:

Collectively, our data strongly suggested the tumor suppressive roles of FOXN4 in breast tumorigenesis via the activation of TP53 while suppressing Notch signaling. Future studies are warranted to explore the clinical application of PF-3084104 (Notch inhibitor) for the treatment of breast cancer patients.

• Authors: Xiao Wang, Dan Su, Zhiquan Qin, Zheling Chen
• Journal: Gene (Gene) Vol. 722 Pg. 144057 (01 05 2020) ISSN: 1879-0038 [Electronic] Netherlands
• PMID: 31430519 (Publication Type: Journal Article, Retracted Publication)
• Copyright: Copyright © 2019. Published by Elsevier B.V.

Chemical References

• Adaptor Proteins, Signal Transducing
• Calcium-Binding Proteins
• DLL4 protein, human
• FOXN4 protein, human
• Forkhead Transcription Factors
• Intercellular Signaling Peptides and Proteins
• Receptors, Notch
• TP53 protein, human
• Tetrahydronaphthalenes
• Tumor Suppressor Protein p53
• Tumor Suppressor Proteins
• Valine
• nirogacestat

Topics

• Adaptor Proteins, Signal Transducing
• Adult
• Animals
• Breast Neoplasms (genetics, metabolism, pathology)
• Calcium-Binding Proteins
• Carcinogenesis
• Cell Line, Tumor
• Cell Proliferation
• Female
• Forkhead Transcription Factors (genetics, metabolism)
• Humans
• Intercellular Signaling Peptides and Proteins (metabolism)
• Mammary Neoplasms, Experimental (drug therapy, genetics, metabolism)
• Mice
• Neoplasm Metastasis
• Prognosis
• Receptors, Notch (antagonists & inhibitors, metabolism)
• Signal Transduction
• Tetrahydronaphthalenes (therapeutic use)
• Tumor Suppressor Protein p53 (genetics, metabolism)
• Tumor Suppressor Proteins (genetics, metabolism)
• Valine (analogs & derivatives, therapeutic use)